Meritxell Arenas/iispv.cat
Jan 26, 2025, 15:04
The 2024 Assisi think tank on breast cancer by Meritxell Arenas et al.
A recent paper titled “The 2024 Assisi think tank on breast cancer: Focus on the use of a tumour bed boost after breast conserving therapy” was published in The Breast Journal by Meritxell Arenas et al.
Authors: Meritxell Arenas, Yasemin Bölükbaşı, Liesbeth Boersma, Cynthia Aristei, Philip Poortmans et al.
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared this article on X, commenting:
“The 2024 Assisi think tank on breast cancer: Focus on the use of a tumour bed boost after breast-conserving therapy
- The Fifth Assisi Think Tank Meeting on breast cancer discussed tumour bed boost.
- Tumour bed boost can reduce local recurrence by up to 50 % but does not impact on overall survival.
- If the estimated absolute reduction in local recurrence exceeds 3 % at 10 years, a boost should be suggested.
- Balancing tumour bed boost benefits with potential side effects is key to achieving optimal outcomes for patients.
- Future research should identify patients who can avoid the boost and refine tumour bed boost volumes for more precise treatments.”
More posts featuring Elisabetta Bonzano.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 26, 2025, 15:04
Jan 26, 2025, 14:53
Jan 26, 2025, 14:50
Jan 26, 2025, 14:42
Jan 26, 2025, 14:34
Jan 26, 2025, 14:23
Jan 26, 2025, 14:22